Literature DB >> 5796364

Cellular transport of L-histidine in Hartnup disease.

S Halvorsen, O Hygstedt, R Jagenburg, O Sjaastad.   

Abstract

The urinary excretion, the intestinal absorption, and the elimination of histidine from blood were studied in two patients with Hartnup disease. On standard diet the patients lost a great proportion of the dietary histidine in the urine, whereas the fecal loss was negligible. A high oral dose of L-histidine gave only a slight increase in plasma histidine and no increase in fecal histidine, but a considerable increase in the urinary histidine output. Intravenously administered L-histidine was eliminated more rapidly than in controls. The lack of increase in plasma histidine after the oral loading may be explained by the rapid elimination from the blood. This was mainly due to a rapid cellular uptake of histidine which is supposed to be a normal reaction of histidine-deprived cells. Thus the only obvious defect in the histidine transport in Hartnup disease is the reabsorption defect in the renal tubules. A generally impaired cellular transport of L-histidine is improbable.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5796364      PMCID: PMC322382          DOI: 10.1172/JCI106121

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

1.  Hartnup disease.

Authors:  K HALVORSEN; S HALVORSEN
Journal:  Pediatrics       Date:  1963-01       Impact factor: 7.124

2.  Indole production in Hartnup disease.

Authors:  A M ASATOOR; J CRASKE; D R LONDON; M D MILNE
Journal:  Lancet       Date:  1963-01-19       Impact factor: 79.321

3.  The effect of semistarvation on absorption by the rat small intestine in vitro and in vivo.

Authors:  T G KERSHAW; K D NEAME; G WISEMAN
Journal:  J Physiol       Date:  1960-06       Impact factor: 5.182

4.  The excretion of amino acids by the human; a quantitative study with ion-exchange chromatography.

Authors:  D F EVERED
Journal:  Biochem J       Date:  1956-03       Impact factor: 3.857

5.  The free amino acids of human blood plasma.

Authors:  W H STEIN; S MOORE
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

6.  Histaminuria in Hartnup disease.

Authors:  O Sjaastad; S Halvorsen
Journal:  Acta Paediatr Scand       Date:  1968-07

7.  Endogenous renal clearance rates of free amino acids in prolinuric and Hartnup patients.

Authors:  K Tada; H Hirono; T Arakawa
Journal:  Tohoku J Exp Med       Date:  1967-09       Impact factor: 1.848

8.  Effects of amino acid loads on a health infant with the biochemical features of Hartnup disease.

Authors:  J W Seakins; R S Ersser
Journal:  Arch Dis Child       Date:  1967-12       Impact factor: 3.791

9.  Observations on nicotinic acid therapy in Hartnup disease.

Authors:  P W Wong; A M Lambert; P M Pillai; P M Jones
Journal:  Arch Dis Child       Date:  1967-12       Impact factor: 3.791

10.  BIOCHEMICAL ASPECTS OF THE HARTNUP DISEASE. I. RESULTS OF INTRAVENOUS AND ORAL TRYPTOPHAN LOADING TESTS IN A CASE OF HARTNUP DISEASE.

Authors:  P DELAEY; C HOOFT; J TIMMERMANS; J SNOECK
Journal:  Ann Paediatr       Date:  1964
View more
  3 in total

1.  A candidate mouse model for Hartnup disorder deficient in neutral amino acid transport.

Authors:  D J Symula; A Shedlovsky; E N Guillery; W F Dove
Journal:  Mamm Genome       Date:  1997-02       Impact factor: 2.957

2.  Intestinal absorption of two dipeptides in Hartnup disease.

Authors:  A M Asatoor; B Cheng; K D Edwards; A F Lant; D M Matthews; M D Milne; F Navab; A J Richards
Journal:  Gut       Date:  1970-05       Impact factor: 23.059

3.  Rare genetic variants affecting urine metabolite levels link population variation to inborn errors of metabolism.

Authors:  Yurong Cheng; Pascal Schlosser; Johannes Hertel; Peggy Sekula; Peter J Oefner; Ute Spiekerkoetter; Johanna Mielke; Daniel F Freitag; Miriam Schmidts; Florian Kronenberg; Kai-Uwe Eckardt; Ines Thiele; Yong Li; Anna Köttgen
Journal:  Nat Commun       Date:  2021-02-11       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.